Cargando…
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry
BACKGROUND: Patients with type-2 diabetes mellitus (T2DM) and hypertension have increased risk of cardiovascular disease (CVD). We studied individualized treatment targets and their achievement in clinical practice. METHODS: DIALOGUE is a prospective, multi-center registry in patients with both T2DM...
Autores principales: | Schmieder, Roland E, Gitt, Anselm K, Koch, Cornelia, Bramlage, Peter, Ouarrak, Taoufik, Tschöpe, Diethelm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426603/ https://www.ncbi.nlm.nih.gov/pubmed/25934177 http://dx.doi.org/10.1186/s12902-015-0020-7 |
Ejemplares similares
-
Individualised treatment targets in patients with type-2 diabetes and hypertension
por: Schmieder, Roland E., et al.
Publicado: (2018) -
Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice – study rationale and protocol of DIALOGUE
por: Gitt, Anselm K, et al.
Publicado: (2012) -
Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry
por: Gitt, Anselm K., et al.
Publicado: (2016) -
The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry
por: Bramlage, Peter, et al.
Publicado: (2015) -
Incidence and predictors of hypoglycaemia in type 2 diabetes – an analysis of the prospective DiaRegis registry
por: Tschöpe, Diethelm, et al.
Publicado: (2012)